Skip to main content
Erschienen in: Clinical Rheumatology 7/2010

01.07.2010 | Brief Report

Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis

verfasst von: Samira Rostom, Karima Benbouaaza, Bouchra Amine, Rachid Bahiri, Yousra Ibn Yacoub, Sanae Ali Ou Alla, Redouane Abouqal, Najia Hajjaj-Hassouni

Erschienen in: Clinical Rheumatology | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

The objectives of this study are to translate, adapt in the Moroccan cultural context, and validate in patients with ankylosing spondylitis (AS) the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The cross-cultural adaptation of the BASFI and BASDAI was obtained in accordance with the guidelines for translation of the health status measures. Eighty-five patients with AS were included in the study. The test–retest reliability and the internal consistency were analyzed, and both questionnaires were assessed for external construct validity. Structural validity was analyzed with correlation matrix. Twenty-four-hour test–retest reliability was good: BASFI intraclass correlation coefficient (ICC) = 0.96 (confidence interval (CI) at 95%, 0.93–0.97), BASDAI ICC = 0.93 (CI at 95%, 0.90–0.95). Cronbach’s alpha was 0.90 for the BASFI and 0.86 for BASDAI. The construct validity of the instruments was evaluated. The BASFI showed a strong validity when correlating its results with Schober’s test (r = −0.56), occipital wall distance (r = 0.46), chest expansion (r = −0.46), BASDAI (r = 0.54), Bath Ankylosing Spondylitis Metrology Index (r = 0.70), Bath Ankylosing Spondylitis Global Score (BAS-G; r = 0.58), Bath Ankylosing Spondylitis Radiology Index (r = 0.61), and the radiological changes in sacroiliac joints (r = 0.54). A good correlation was observed between the BASDAI and the spinal pain (r = 0.53), the number of nocturnal awakenings (r = 0.57), the morning stiffness (r = 0.65), the enthesic index (r = 0.47), the BAS-G (r = 0.53), the BASFI (r = 0.54), and the erythrocyte sedimentation rate (r = 0.41; for all p < 0.001). The correlation matrix showed an intermediate correlation between items. The Moroccan version of the BASFI and the BASDAI showed adequate reliability and validity. These instruments can be used in the clinical evaluation of Moroccan and Arabic-speaking patients with AS.
Literatur
1.
Zurück zum Zitat van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N (1999) Selection of instruments in the core set for DC-art, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS working group. Assessments in Ankylosing Spondylitis. J Rheumatol 26(4):951–954PubMed van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N (1999) Selection of instruments in the core set for DC-art, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS working group. Assessments in Ankylosing Spondylitis. J Rheumatol 26(4):951–954PubMed
2.
Zurück zum Zitat Calin A, Garett S, Tenkinson T, Kenedy LG, Whelack H (1994) A new approach to defining functional ability in AS: the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 2:2281–2285 Calin A, Garett S, Tenkinson T, Kenedy LG, Whelack H (1994) A new approach to defining functional ability in AS: the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 2:2281–2285
3.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291PubMed
4.
Zurück zum Zitat Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35:66–71CrossRefPubMed Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35:66–71CrossRefPubMed
5.
Zurück zum Zitat Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Calin A (1994) Defining spinal mobility in ankylosing spondylitis. The Bath AS Metrology Index(AS). J Rheumatol 21:1694–1698PubMed Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Calin A (1994) Defining spinal mobility in ankylosing spondylitis. The Bath AS Metrology Index(AS). J Rheumatol 21:1694–1698PubMed
6.
Zurück zum Zitat MacKay K, Mack C, Brophy S, Calin A (1998) The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 41:2263–2270CrossRefPubMed MacKay K, Mack C, Brophy S, Calin A (1998) The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 41:2263–2270CrossRefPubMed
7.
Zurück zum Zitat Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidem 46:1417–1432CrossRef Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidem 46:1417–1432CrossRef
8.
Zurück zum Zitat Guillemin F (1995) Cross cultural adaptation and validation of health status measures. Scand J Rheumatol 24:61–63CrossRefPubMed Guillemin F (1995) Cross cultural adaptation and validation of health status measures. Scand J Rheumatol 24:61–63CrossRefPubMed
9.
Zurück zum Zitat Pouchot J, Larbre JP, Lemelle I, Guillemin F, Prieur AM (2002) Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis. Jt Bone Spine 69:468–481CrossRef Pouchot J, Larbre JP, Lemelle I, Guillemin F, Prieur AM (2002) Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis. Jt Bone Spine 69:468–481CrossRef
10.
Zurück zum Zitat Faucher M, Poiraudeau S, Lefevre-Colau MM, Rannou F, Fermanian J, Revel M (2003) Assessment of the test–retest reliability and construct validity of a modified Lequesne index in knee osteoarthritis. Joint Bone Spine 70:521–525CrossRefPubMed Faucher M, Poiraudeau S, Lefevre-Colau MM, Rannou F, Fermanian J, Revel M (2003) Assessment of the test–retest reliability and construct validity of a modified Lequesne index in knee osteoarthritis. Joint Bone Spine 70:521–525CrossRefPubMed
11.
Zurück zum Zitat Schwartz D. Méthodes statistiques à l’usage des médecins et des biologistes. Ed Flammarion, 4ème Edition. Collection «statistique en biologie et en médecine», 1, Paris 1995: 20–42 Schwartz D. Méthodes statistiques à l’usage des médecins et des biologistes. Ed Flammarion, 4ème Edition. Collection «statistique en biologie et en médecine», 1, Paris 1995: 20–42
12.
Zurück zum Zitat El Miedany YM, El Gafary M, Ahmed I (2003) Cross-cultural adaptation and validation of an arabic health assessment questionnaire for use in rheumatoid arthritis patients. Joint Bone Spine 70:195–202CrossRef El Miedany YM, El Gafary M, Ahmed I (2003) Cross-cultural adaptation and validation of an arabic health assessment questionnaire for use in rheumatoid arthritis patients. Joint Bone Spine 70:195–202CrossRef
13.
Zurück zum Zitat Claudepierre P, Sibilia J, Goupille FRM, Wendling D, Chevalier X (1994) Evaluation of a french version of the Bath Ankylosing Spondylitis Functional Index in patients with spondylarhtropathy. J Rheumatol 21:2281–2285 Claudepierre P, Sibilia J, Goupille FRM, Wendling D, Chevalier X (1994) Evaluation of a french version of the Bath Ankylosing Spondylitis Functional Index in patients with spondylarhtropathy. J Rheumatol 21:2281–2285
14.
Zurück zum Zitat Cronstedt H, Waldner A, Stenstrom CH (1999) The Swedish version of the Bath Ankylosing Spondylitis Functional Index. Reliability and validity. Scand J Rheumtol 28:1111–1119 Cronstedt H, Waldner A, Stenstrom CH (1999) The Swedish version of the Bath Ankylosing Spondylitis Functional Index. Reliability and validity. Scand J Rheumtol 28:1111–1119
15.
Zurück zum Zitat Ruof J, Sangha O, Stucki G (1999) Evaluation of German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados functional index (D-FI). Z Rheumtol 58:218–225CrossRef Ruof J, Sangha O, Stucki G (1999) Evaluation of German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados functional index (D-FI). Z Rheumtol 58:218–225CrossRef
16.
Zurück zum Zitat Hecnikkila S, Viitanen JV, Kautianen H et al (2000) Evaluation of the Finnish versions of the functional indices: BASFI and DFI in spondylartropathy. Clin Rheumtol 19:464–469CrossRef Hecnikkila S, Viitanen JV, Kautianen H et al (2000) Evaluation of the Finnish versions of the functional indices: BASFI and DFI in spondylartropathy. Clin Rheumtol 19:464–469CrossRef
17.
Zurück zum Zitat Cariel MH, Londono JD, Gutierrez E, Pacheco-Tena C et al (2003) Translation, cross-cultural adaptation and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados functional index (DFI) in Spanish speaking population with spondylartropathy. Clin Exp Rheumatol 21:451–458 Cariel MH, Londono JD, Gutierrez E, Pacheco-Tena C et al (2003) Translation, cross-cultural adaptation and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados functional index (DFI) in Spanish speaking population with spondylartropathy. Clin Exp Rheumatol 21:451–458
18.
Zurück zum Zitat Karatepe AG, AkkocY AS, Akkoc N (2005) The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity. Rheumatol Int 25:612–618CrossRefPubMed Karatepe AG, AkkocY AS, Akkoc N (2005) The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity. Rheumatol Int 25:612–618CrossRefPubMed
19.
Zurück zum Zitat Udrea G, Ciobanu C, Mihai C, Stoica V, Suteanu S, van der Heijde D, van der Linden S (2004) Evaluation of a Romanian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) in patients with AS. Rom J Intern Med 42:199–209PubMed Udrea G, Ciobanu C, Mihai C, Stoica V, Suteanu S, van der Heijde D, van der Linden S (2004) Evaluation of a Romanian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) in patients with AS. Rom J Intern Med 42:199–209PubMed
20.
Zurück zum Zitat Claudepierre P, Sibilia J, Goupille P et al (1997) Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondylarhtropathiy. J Rheumatol 24:1954–1958PubMed Claudepierre P, Sibilia J, Goupille P et al (1997) Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondylarhtropathiy. J Rheumatol 24:1954–1958PubMed
21.
Zurück zum Zitat Cronstedt H, Waldner A (1999) Stenstrom CH The Swedish version of the Bath Ankylosing Spondylitis Disease Activity Index. Reliability and validity. Scand J Rheumtol 111:10–16 Cronstedt H, Waldner A (1999) Stenstrom CH The Swedish version of the Bath Ankylosing Spondylitis Disease Activity Index. Reliability and validity. Scand J Rheumtol 111:10–16
22.
Zurück zum Zitat Brandt J, Westhof G, Rudwaleit M, Listing J, Zink A, Braun J, Sieper J (2003) Adaptation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany. Z Rheumtol 62:264–273 Brandt J, Westhof G, Rudwaleit M, Listing J, Zink A, Braun J, Sieper J (2003) Adaptation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany. Z Rheumtol 62:264–273
23.
Zurück zum Zitat Karatepe AG, Akkoc Y, Akar S et al (2005) The Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25:280–2844CrossRefPubMed Karatepe AG, Akkoc Y, Akar S et al (2005) The Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25:280–2844CrossRefPubMed
24.
Zurück zum Zitat El Miedany Y, Youssef S, Mehanna A et al (2008) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG). Clin Rheumatol 27(5):605–612CrossRefPubMed El Miedany Y, Youssef S, Mehanna A et al (2008) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG). Clin Rheumatol 27(5):605–612CrossRefPubMed
25.
Zurück zum Zitat Wei JC, Wong RH, Huang JH, Yu CT, Chou CT, Jan MS, Tsay GJ,1-- Chou MC, Lee HS (2007) Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan. Clin Rheumatol 26(10):1685–1691CrossRefPubMed Wei JC, Wong RH, Huang JH, Yu CT, Chou CT, Jan MS, Tsay GJ,1-- Chou MC, Lee HS (2007) Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan. Clin Rheumatol 26(10):1685–1691CrossRefPubMed
Metadaten
Titel
Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis
verfasst von
Samira Rostom
Karima Benbouaaza
Bouchra Amine
Rachid Bahiri
Yousra Ibn Yacoub
Sanae Ali Ou Alla
Redouane Abouqal
Najia Hajjaj-Hassouni
Publikationsdatum
01.07.2010
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 7/2010
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1431-5

Weitere Artikel der Ausgabe 7/2010

Clinical Rheumatology 7/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.